*Japanese*
Digestive organs internal medicine
The Wnt/β-Catenin Inhibitor HC-1 Suppresses Liver Fibrosis by Inhibiting Activated Hepatic Stellate Cells and Inducing Matrix Metalloproteinase-1. , Hatakeyama D, Itaba N, Shimizu H, Morimoto M, Shiota G , Yonago Acta Med , vol.68 (p.131 - 143) , 2025 , The Multiple Authorship , English
Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice. , Fukushima K, Itaba N, Kono Y, Okazaki S, Enokida S, Kuranobu N, Murakami J, Enokida M, Nagashima H, Kanzaki S, Namba N, Shiota G , Regen Ther , vol.18 (p.292 - 301) , 2021 , The Multiple Authorship , English
WNT/β-catenin Signal Inhibitor IC-2-derived Small-Molecule Compounds Suppress TGF-β1-induced Fibrogenic Response of Renal Epithelial Cells by Inhibiting SMAD2/3 Signalling. , Hoi S, Tsuchiya H, Itaba N, Suzuki K, Oka H, Morimoto M, Takata T, Isomoto H, and Shiota G , Clin Exp Pharmacol Physiol , vol.47 (p.940 - 946) , 2020 , There is Review , The Multiple Authorship , English
dentification of a Novel Deactivating Small-molecule Compound for Fibrogenic Hepatic Stellate Cells. , Sakaguchi T, Kono Y, Itaba N, Morimoto M, Isomoto H, and Shiota G. , Yonago Acta Med , vol.63 (p.79 - 87) , 2020 , There is Review , The Multiple Authorship , English
Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets. , Itaba N, Kono Y, Watanabe K, Yokobata T, Oka H, Osaki M, Kakuta H, Morimoto M, and Shiota G , Sci Rep , vol.9 (p.6841 - ) , 2019 , The Multiple Authorship , English
Progress in stem cell-based therapy for liver disease. , Shiota Goshi,Itaba Noriko , Hepatology research , , vol.47 (2) (p.127 - 141) , 2017.02 , Shiota Goshi,Itaba Noriko , Learned Journal , The Multiple Authorship , English
Updated on 2025/10/30